You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

biotechnology

Showing 1 - 25 of 1,293
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and

Recruiting
  • Bioequivalence
  • Schizophrenia
  • Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023

COVID-19 Pandemic Trial (Lyophilized COVID-19 mRNA Vaccine, Sodium chloride)

Not yet recruiting
  • COVID-19 Pandemic
  • Lyophilized COVID-19 mRNA Vaccine
  • Sodium chloride
  • (no location specified)
Nov 18, 2022

Multiple Myeloma Trial in Shanghai (GC012F injection)

Not yet recruiting
  • Multiple Myeloma
  • GC012F injection
  • Shanghai, Shanghai, China
    Shanghai Changzheng Hospital
May 1, 2023

Infertility, Fertility Disorders Trial (ZyMot Multi (850µL), Density Gradient Centrifugation)

Not yet recruiting
  • Infertility
  • Fertility Disorders
  • ZyMōt Multi (850µL)
  • Density Gradient Centrifugation
  • (no location specified)
Nov 16, 2023

Advanced Solid Tumor Trial in Shanghai (Personalized neoantigen tumor vaccine)

Recruiting
  • Advanced Solid Tumor
  • Personalized neoantigen tumor vaccine
  • Shanghai, Shanghai, China
    Ruijin Hospital Shanghai Jiaotong University School of Medicine
Jun 24, 2023

Multiple Myeloma Trial in Xuzhou (APRIL-BAFF-Bicephali CAR-T cells)

Recruiting
  • Multiple Myeloma
  • APRIL-BAFF-Bicephali CAR-T cells
  • Xuzhou, Jiangsu, China
    Kailin Xu
Nov 14, 2023

Phenylketonuria Trial (CBT102-A capsule, Placebo capsule)

Not yet recruiting
  • Phenylketonuria
  • CBT102-A capsule
  • Placebo capsule
  • (no location specified)
Jul 9, 2023

Single-Cell Transcriptomics of Peritoneal Microenvironment of

Recruiting
  • Peritoneal Metastases
  • CRC+HIPEC
  • Ghent, Oost-Vlaanderen, Belgium
    UZ Ghent
Dec 22, 2022

Locally Advanced Rectal Cancer Trial in Guangzhou (AK104, Capecitabine, Neoadjuvant Radiotherapy)

Not yet recruiting
  • Locally Advanced Rectal Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Aug 5, 2023

GastroEsophageal Cancer, Gastric Cancer Trial in Tampa (Neratinib, Trastuzumab, Oxaliplatin)

Recruiting
  • GastroEsophageal Cancer
  • Gastric Cancer
  • Tampa, Florida
    Moffitt Cancer Center
Oct 25, 2023

Idiopathic Parkinson's Disease Trial in Shanghai (hAESCs)

Not yet recruiting
  • Idiopathic Parkinson's Disease
  • hAESCs
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Jan 28, 2023

Precise Prediction of Therapy Efficiency Trial (biopsy of tumor before treatment)

Not yet recruiting
  • Precise Prediction of Therapy Efficiency
  • biopsy of tumor before treatment
  • (no location specified)
Jan 31, 2023

Kidney Failure, Chronic Trial in Birmingham (UKidney)

Not yet recruiting
  • Kidney Failure, Chronic
  • UKidney
  • Birmingham, Alabama
    University of Alabama Birmingham
Jan 24, 2023

Retinitis Pigmentosa Trial in Ankara (Wharton's jelly derived mesenchymal stemcells, Magnovision)

Completed
  • Retinitis Pigmentosa
  • Wharton's jelly derived mesenchymal stemcells
  • Magnovision
  • Ankara, Gölbaşı, Turkey
  • +2 more
Mar 23, 2023

Epilepsy, Temporal Lobe, Drug Resistant Epilepsy Trial in Melbourne (NaviFUS System)

Recruiting
  • Epilepsy, Temporal Lobe
  • Drug Resistant Epilepsy
  • NaviFUS System
  • Melbourne, Victoria, Australia
    The Alfred
Jul 7, 2023

Advanced Solid Tumor Trial in Beijing (YK0901 cells)

Not yet recruiting
  • Advanced Solid Tumor
  • YK0901 cells
  • Beijing, China
    Department of GI Oncology, Peking University Cancer Hospital
Jun 27, 2023

Relapsed or Refractory Multiple Myeloma Trial in Tianjin (YTS104 Cells injection)

Not yet recruiting
  • Relapsed or Refractory Multiple Myeloma
  • YTS104 Cells injection
  • Tianjin, Tianjin, China
    Institute of Hematology & Blood Diseases Hospital
Jun 13, 2023

NK Cell, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory Trial in Hubei (autologous NK cell)

Not yet recruiting
  • NK Cell
  • +2 more
  • autologous NK cell
  • Hubei, Xiangyang, China
    EC of Xiangyang No.1 People's Hospital Hubei University of Medic
Jun 19, 2023

Rectal Cancer Patients Based on ctDNA-MRD Technology

Recruiting
  • Rectal Adenocarcinoma
  • +3 more
  • MRD detection
  • Guangzhou, Guangdong, China
    WeiWei Xiao
Jul 31, 2023

CAR-T Cell Therapy Trial in Shanghai (GC012F injection)

Recruiting
  • CAR-T Cell Therapy
  • GC012F injection
  • Shanghai, Shanghai, China
    Department of Rheumatology, Ren Ji Hospital South Campus, School
May 5, 2023

Anterior Cruciate Ligament Rupture Trial (Absorbable interface screws manufactured by Natong Biotechnology, Absorbable interface

Not yet recruiting
  • Anterior Cruciate Ligament Rupture
  • Absorbable interface screws manufactured by Natong Biotechnology
  • Absorbable interface screws manufactured by INION.
  • (no location specified)
Jun 20, 2022

CAR-T Trial in Hangzhou (GC012F injection)

Recruiting
  • CAR-T
  • GC012F injection
  • Hangzhou, Zhejiang, China
    The First Affiliated Hospital,College of Medicine, Zhejiang Univ
May 10, 2023

Osteoporosis, Postmenopausal Trial in Yantai (Denosumab)

Recruiting
  • Osteoporosis, Postmenopausal
  • Denosumab
  • Yantai, Shandong, China
    Shandong Boan Biotechnology Co., Ltd.
May 2, 2023

Heart Failure, Dilated Cardiomyopathy Trial in Shanghai (JV001)

Recruiting
  • Heart Failure
  • Dilated Cardiomyopathy
  • JV001
  • Shanghai, Shanghai, China
    Shanghai East Hospital
Apr 19, 2023

Hepatocellular Carcinoma Trial in Wuhan (Nocardia rubra cell wall skeleton, Hepatic arterial infusion chemo, Lenvatinib)

Recruiting
  • Hepatocellular Carcinoma
  • Nocardia rubra cell wall skeleton
  • +3 more
  • Wuhan, Hubei, China
    Hepatic Surgery Center, Tongji Hospital, Tongji Medical College,
Sep 5, 2022